Tomesa balneophototherapy in mild to severe psoriasis: a retrospective clinical trial in 174 patients

Authors

  • Angelo Cattaneo,

    1. U.O. Dermatologia, Fondazione IRCCS Ca’ Granda – Ospedale Maggiore Policlinico, Milano, Italy
    Search for more papers by this author
  • Silvia Alberti Violetti,

    1. Department of Anesthesia, Intensive Care and Dermatologic Sciences, Università degli Studi di Milano, U.O. Dermatologia, Fondazione IRCCS Ca’ Granda – Ospedale Maggiore Policlinico, Milano, Italy
    Search for more papers by this author
  • Simona Tavecchio,

    1. Department of Anesthesia, Intensive Care and Dermatologic Sciences, Università degli Studi di Milano, U.O. Dermatologia, Fondazione IRCCS Ca’ Granda – Ospedale Maggiore Policlinico, Milano, Italy
    Search for more papers by this author
  • Elena Bruni,

    1. Department of Anesthesia, Intensive Care and Dermatologic Sciences, Università degli Studi di Milano, U.O. Dermatologia, Fondazione IRCCS Ca’ Granda – Ospedale Maggiore Policlinico, Milano, Italy
    Search for more papers by this author
  • Carlo Carrera,

    1. U.O. Dermatologia, Fondazione IRCCS Ca’ Granda – Ospedale Maggiore Policlinico, Milano, Italy
    Search for more papers by this author
  • Carlo Crosti

    1. Department of Anesthesia, Intensive Care and Dermatologic Sciences, Università degli Studi di Milano, U.O. Dermatologia, Fondazione IRCCS Ca’ Granda – Ospedale Maggiore Policlinico, Milano, Italy
    Search for more papers by this author

  • Conflicts of interest:

    None declared.

Correspondence:

Dr Simona Tavecchio, M.D., Dipartimento di Anestesiologia, Terapia Intensiva e Scienze Dermatologiche, U.O. Dermatologia, Fondazione IRCCS Ca’ Granda – Ospedale Maggiore Policlinico, Via Pace 9- 20122 Milan, Italy.

Tel: +39 0255035106

Fax: +39 0250320779

e-mail: simona.tavecchio@gmail.com

Summary

Psoriasis is a chronic inflammatory skin disease with a high social and psychological impact on the quality of life of patients. Tomesa balneophototherapy is based on bathing in a magnesium-rich salt solution combined with exposure to narrowband ultraviolet B phototherapy. We conducted a retrospective clinical trial on 174 patients affected by mild to severe psoriasis undergoing Tomesa balneophototherapy. The basal course consisted of three to five sessions per week for a total of 30 sessions. Subsequently, patients could continue with a maintenance course of one session per week for a total of 30 sessions. We recorded a significant reduction of the mean Psoriasis Area and Severity Index (PASI) index with an achievement of at least PASI 75 in 52.1% of the 119 patients who completed the basal course and an improvement of the ‘quality of life’ of patients. The good efficacy obtained by this treatment, and the psychological impact on the quality of life of patients, demonstrated that Tomesa balneophototherapy could be a good option for the treatment of a chronic disease associated with psychological distress, like psoriasis.

Ancillary